Drugs & OTC

Cann Global Limited (ASX:CGB) Secures Global Rights to Olivias Choice Formulas

🕔12/10/2019 9:20:47 AM

Board of Cann Global Limited (ASX:CGB) is delighted to announce an agreement to secure the exclusive rights to the IP of the unique medicinal cannabis formulations that have been used by Olivia Newton John in her recent health challenge.

Read Full Article

Cann Global Limited (ASX:CGB) Operational Update

🕔12/6/2019 8:22:48 AM

Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's operations of business for three of its divisions and its mining interest.

Read Full Article

Cann Global Limited (ASX:CGB) Chairperson's Address to 2019 AGM

🕔11/28/2019 2:55:41 PM

Cann Global Limited (ASX:CGB) has been achieving significant milestones in these past 12 months. The most notable being the undertaking and successful completion of a very extensive and technically comprehensive re-compliance process

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Anatara Investor Presentation and Update

🕔11/28/2019 8:30:18 AM

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will present today at the Pitt Street Research Life Sciences Conference, held in Sydney, NSW.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) R&D Tax Incentive Received

🕔11/22/2019 8:21:55 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $847,325 from the Australian Taxation Office under the Federal Government's Research and Development (R&D) tax incentive scheme.

Read Full Article

Anatara Lifsciences Ltd (ASX:ANR) CEO Steve Lydeamore To Present at the Pitt Street Research Life Sciences Conference

🕔11/18/2019 1:17:55 PM

Anatara's CEO Steve Lydeamore has been invited to present at the Pitt Street Research Life Sciences Conference on the 28th November in Sydney. Any investors interested in attending these presentations are invited to reach out.

Read Full Article

FINANCE VIDEO: Anatara Lifesciences Ltd (ASX:ANR) Interview with CEO Steve Lydeamore

🕔11/15/2019 7:46:07 AM

Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore is interviewed by ABN Newswire, and talks about the human trials as well as the product pipeline for next year.

Read Full Article